Angeliq 28 tablets — Made in Germany by Bayer — Free Delivery

Product description 

Tablets "Angeliq" are used for the following indications:

• hormone replacement therapy (HRT) for symptoms of estrogen deficiency in postmenopausal women more than one year after menopause;
• prevention of osteoporosis in postmenopausal women who are at increased risk of developing bone fractures and have intolerance to other preparations used to prevent osteoporosis, or for whom such preparations are contraindicated.
• The experience of using the preparation in women over the age of 65 years is limited.

Compound

One tablet contains (active ingredients):

estradiol (in the form of estradiol hemihydrate) - 1.0 mg;

drospirenone - 2.0 mg.

Excipients: lactose monohydrate, corn starch, pregelatinized starch, povidone 25000, magnesium stearate, hydroxypropyl methylcellulose, macrogol 6000, talc, titanium dioxide (E 171), iron oxide red (E 172).

Contraindications

• genital bleeding of unknown etiology;
• breast cancer, suspicion of it, or the presence of a specified pathology in history;
• estrogen-dependent malignant tumors or suspicion of them (for example, endometrial cancer);
• untreated endometrial hyperplasia;
• venous thromboembolism or the presence of a specified pathology in history (deep vein thrombosis, pulmonary embolism);
• arterial thromboembolism in the acute stage or recently transferred (for example, angina pectoris, myocardial infarction, stroke);
• high risk of venous or arterial thrombosis;
• acute liver disease or a history of liver disease until liver function tests return to normal;
• severe liver disease;
• current or history of liver tumors (benign or malignant);
• tendency to develop thrombosis (for example, protein C deficiency, protein S deficiency or antithrombin);
• impaired renal function or acute renal failure;
• insufficiency of the adrenal glands;
• known anaphylactic reactions, Quincke's edema, hypersensitivity to the active substances or to any of the excipients of the preparation;
• porphyria;
• severe hypertriglyceridemia.

Mode of application

If HRT was prescribed for the first time or there is a transition to Angeliq from a combined preparation for continuous HRT, then taking Angeliq tablets can be started at any time. If there is a transition to "Angeliq" from a cyclic combination preparation for HRT, the current cycle of therapy should be completed before starting the use of the preparation "Angeliq".

Dosages - one tablet per day. Each package is designed for a 28-day course of treatment.

Take the tablet without chewing with a small amount of liquid. The treatment is carried out continuously, that is, taking the tablets from the next package is started immediately after the end of the previous package, without any intervals. Tablets should preferably be taken at the same time. If there is a delay in taking the next pill, you should take it as soon as possible. If the next tablet has not been taken for more than 24 hours, you do not need to take an additional tablet. If several tablets were missed in a row, bleeding may begin.

For the treatment of postmenopausal symptoms, the lowest effective dose is used.

The lowest effective dose for the shortest duration is used to initiate and continue therapy for postmenopausal symptoms.

Application features

pregnant

The preparation "Angeliq" is contraindicated in pregnant women and women who are breastfeeding.

Children

The preparation "Angeliq" is not ostentatious for use in children and adolescents.

Drivers

The preparation does not affect the reaction rate when driving vehicles or working with other mechanisms.

Overdose

In clinical studies conducted with the participation of male volunteers, doses up to 100 mg of drospirenone were well tolerated. Based on the general experience with the use of combined oral contraceptives, it has been established that overdose can cause nausea, vomiting and vaginal bleeding in girls and some women. There is no specific antidote, treatment should be symptomatic.

Side effects

The most commonly reported adverse reactions with Angeliq were breast pain (> 10%) and, during the first months of therapy, bleeding and spotting (> 10%), which usually disappeared as treatment continued. The frequency of bleeding decreases as the duration of therapy increases.

Storage conditions

Store at a temperature not exceeding 25 ° C, out of the reach of children.

Shelf life - 5 years.

There are no reviews for this product.